PHE Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Cipher Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 10.1 EUR

Market Cap: €258.4m

C	Cipher Pharmaceuticals Inc F:PHE	CA
	Relo Group Inc TSE:8876	JP
D	DBS Group Holdings Ltd XMUN:DEVL	SG
L	Life Storage Inc F:SOV	US
	DBS Group Holdings Ltd F:DEVL	SG
R	Ratch Group PCL SET:RATCH	TH
	DBS Group Holdings Ltd F:DEV	SG
	Sofina SA XBRU:SOF	BE
S	StoneCo Ltd XMUN:0Q0	KY
	Aditya Birla Fashion and Retail Ltd BSE:535755	IN
R	Rojukis International PCL SET:KISS	TH
M	Molecular Templates Inc F:NZW1	US
	H & M Hennes & Mauritz AB STO:HM B	SE
	US Energy Corp NASDAQ:BSIN	US
	Bosch Ltd NSE:BOSCHLTD	IN
	Quest Resource Holding Corp NASDAQ:QRHC	US

Profitability Summary

Cipher Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

80%

Strong 3Y Average Gross Margin

78%

Declining Gross Margin

81% > 80%

Exceptional Operating Margin

33%

Strong 3Y Average Operating Margin

36%

Declining Operating Margin

47% > 33%

Exceptional Net Margin

54%

Strong 3Y Average Net Margin

75%

Declining Net Margin

141% > 54%

Exceptional Free Cash Flow Margin

59%

Negative 3Y Average Free Cash Flow Margin

-21%

Declining Free Cash Flow Margin

65% > 59%

Positive ROE

24%

Exceptional 3Y Average ROE

Exceptional 3Y Average ROIC

40%

Declining ROIC

72% > 19%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.